FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085969069> ?p ?o ?g. }

• W2085969069 endingPage "537" @default.
• W2085969069 startingPage "525" @default.
• W2085969069 abstract "Objectives Aspirin (ASA), a major antiplatelet and cancer-preventing drug, irreversibly blocks the cyclooxygenase (COX) activity of prostaglandin H synthase-1 (PGHS-1). Considerable differences in ASA effectiveness are observed between individuals, and some of this variability may be due to PGHS-1 protein variants. Our overall aim is to determine which, if any, of the known variants in the mature PGHS-1 protein lead to functional alterations in COX catalysis or inhibition by ASA. The present study targeted four PGHS-1 variants: R53H, R108Q, L237M, and V481I. Methods Wild-type human PGHS-1 and the four polymorphic variants were expressed as histidine-tagged, homodimeric proteins in insect cells using baculovirus vectors, solubilized with a detergent, and purified by affinity chromatography. The purified proteins were characterized in vitro to evaluate COX and peroxidase (POX) catalytic parameters and the kinetics of COX inhibition by ASA and NS-398. Results Compared with the wild type, several variants showed a higher COX/POX ratio (up to 1.5-fold, for R108Q), an elevated arachidonate Km (up to 1.9-fold, for R108Q), and/or a lower ASA reactivity (up to 60% less, for R108Q). The decreased ASA reactivity in R108Q reflected both a 70% increase in the Ki for ASA and a 30% decrease in the rate constant for acetyl group transfer to the protein. Computational modeling of the brief ASA pulses experienced by PGHS-1 in circulating platelets during daily ASA dosing predicted that the 60% lower ASA reactivity in R108Q yields a 15-fold increase in surviving COX activity; smaller, approximately two-fold increases in surviving COX activity were predicted for L237M and V481I. NS-398 competitively inhibited COX catalysis of the wild type (Ki=6 µmol/l) and inhibited COX inactivation by 1.0 mmol/l ASA in both the wild type (IC50=0.8 µmol/l) and R108Q (IC50=2.1 µmol/l). Conclusion Of the four PGHS-1 variants examined, R108Q exerts the largest functional effects, with evidence for impaired interactions with a COX substrate and inhibitors. As Arg108 is located on the protein surface and not in the active site, the effects of R108Q suggest a novel, unsuspected mechanism for the modulation of the PGHS-1 active site structure. The lower intrinsic ASA reactivity of R108Q, V481I, and L237M, combined with the rapid hydrolysis of ASA in the blood, suggests that these variants decrease the antiplatelet effectiveness of the drug. These PGHS-1 variants are uncommon but ASA is used widely; hence, a considerable number of individuals could be affected. Further examination of these and other PGHS-1 variants will be needed to determine whether PGHS-1 genotyping can be used to personalize anti-COX therapy." @default.
• W2085969069 created "2016-06-24" @default.
• W2085969069 creator A5001969147 @default.
• W2085969069 creator A5051334500 @default.
• W2085969069 creator A5053520269 @default.
• W2085969069 creator A5074259922 @default.
• W2085969069 date "2012-07-01" @default.
• W2085969069 modified "2023-10-04" @default.
• W2085969069 title "Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1" @default.
• W2085969069 cites W1241551828 @default.
• W2085969069 cites W14381655 @default.
• W2085969069 cites W1518533198 @default.
• W2085969069 cites W1537738331 @default.
• W2085969069 cites W1573664132 @default.
• W2085969069 cites W1967869710 @default.
• W2085969069 cites W1971443047 @default.
• W2085969069 cites W1980990431 @default.
• W2085969069 cites W1983131031 @default.
• W2085969069 cites W1984820457 @default.
• W2085969069 cites W1987212025 @default.
• W2085969069 cites W1989983940 @default.
• W2085969069 cites W1993938520 @default.
• W2085969069 cites W2006703045 @default.
• W2085969069 cites W2007019274 @default.
• W2085969069 cites W2014770448 @default.
• W2085969069 cites W2017423772 @default.
• W2085969069 cites W2022234965 @default.
• W2085969069 cites W2023302278 @default.
• W2085969069 cites W2024715019 @default.
• W2085969069 cites W2026263808 @default.
• W2085969069 cites W2035882831 @default.
• W2085969069 cites W2038410983 @default.
• W2085969069 cites W2040953136 @default.
• W2085969069 cites W2045934073 @default.
• W2085969069 cites W2046290668 @default.
• W2085969069 cites W2050693842 @default.
• W2085969069 cites W2050993188 @default.
• W2085969069 cites W2054535723 @default.
• W2085969069 cites W2059146988 @default.
• W2085969069 cites W2065204483 @default.
• W2085969069 cites W2068364168 @default.
• W2085969069 cites W2074631079 @default.
• W2085969069 cites W2078620724 @default.
• W2085969069 cites W2081246578 @default.
• W2085969069 cites W2081590184 @default.
• W2085969069 cites W2084526185 @default.
• W2085969069 cites W2100837269 @default.
• W2085969069 cites W2102252666 @default.
• W2085969069 cites W2108925673 @default.
• W2085969069 cites W2118188075 @default.
• W2085969069 cites W2118655751 @default.
• W2085969069 cites W2138824201 @default.
• W2085969069 cites W2140482107 @default.
• W2085969069 cites W2142596581 @default.
• W2085969069 cites W2146306600 @default.
• W2085969069 cites W2151036184 @default.
• W2085969069 cites W2158960911 @default.
• W2085969069 cites W989142126 @default.
• W2085969069 doi "https://doi.org/10.1097/fpc.0b013e32835366f6" @default.
• W2085969069 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3376194" @default.
• W2085969069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22513397" @default.
• W2085969069 hasPublicationYear "2012" @default.
• W2085969069 type Work @default.
• W2085969069 sameAs 2085969069 @default.
• W2085969069 citedByCount "9" @default.
• W2085969069 countsByYear W20859690692014 @default.
• W2085969069 countsByYear W20859690692015 @default.
• W2085969069 countsByYear W20859690692016 @default.
• W2085969069 countsByYear W20859690692017 @default.
• W2085969069 countsByYear W20859690692018 @default.
• W2085969069 countsByYear W20859690692020 @default.
• W2085969069 countsByYear W20859690692021 @default.
• W2085969069 countsByYear W20859690692023 @default.
• W2085969069 crossrefType "journal-article" @default.
• W2085969069 hasAuthorship W2085969069A5001969147 @default.
• W2085969069 hasAuthorship W2085969069A5051334500 @default.
• W2085969069 hasAuthorship W2085969069A5053520269 @default.
• W2085969069 hasAuthorship W2085969069A5074259922 @default.
• W2085969069 hasBestOaLocation W20859690692 @default.
• W2085969069 hasConcept C112243037 @default.
• W2085969069 hasConcept C181199279 @default.
• W2085969069 hasConcept C185592680 @default.
• W2085969069 hasConcept C2777628954 @default.
• W2085969069 hasConcept C2779689624 @default.
• W2085969069 hasConcept C2780664492 @default.
• W2085969069 hasConcept C2780978440 @default.
• W2085969069 hasConcept C55493867 @default.
• W2085969069 hasConcept C86803240 @default.
• W2085969069 hasConcept C98274493 @default.
• W2085969069 hasConceptScore W2085969069C112243037 @default.
• W2085969069 hasConceptScore W2085969069C181199279 @default.
• W2085969069 hasConceptScore W2085969069C185592680 @default.
• W2085969069 hasConceptScore W2085969069C2777628954 @default.
• W2085969069 hasConceptScore W2085969069C2779689624 @default.
• W2085969069 hasConceptScore W2085969069C2780664492 @default.
• W2085969069 hasConceptScore W2085969069C2780978440 @default.
• W2085969069 hasConceptScore W2085969069C55493867 @default.
• W2085969069 hasConceptScore W2085969069C86803240 @default.

• next